메뉴 건너뛰기




Volumn 404, Issue 6-7, 2012, Pages 1831-1838

A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry

Author keywords

GC MS MS; Pharmacokinetics; Plasma; Sulfolane .Busulfan .Metabolite; Therapeutic drugmonitoring

Indexed keywords

ADVERSE EVENTS; ANALYTES; ANALYTICAL METHOD; BUSULFAN; CLINICAL STUDY; CONCENTRATION RANGES; ELECTRONIC IMPACT; GAS CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; GC-MS/MS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH DOSE; LIQUID-LIQUID EXTRACTION; LOWER LIMIT OF QUANTIFICATIONS; MASS SPECTROMETRIC DETECTION; PEDIATRIC PATIENTS; PLASMA SAMPLES; RELATIVE STANDARD DEVIATIONS; SELECTED REACTION MONITORING; SULFOLANE; THERAPEUTIC DRUGMONITORING; TRIPLE QUADRUPOLE;

EID: 84867333034     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6330-y     Document Type: Article
Times cited : (15)

References (22)
  • 16
    • 84875373990 scopus 로고    scopus 로고
    • Accessed 6 Feb 2012
    • European Medicines Agency (EMEA). Draft guidelines on validation of bioanalytical methods (2012) http://www.ema.europa.eu/docs/en-GB/document- library/Scientific-guideline/2011/08/WC500109686.pdf. Accessed 6 Feb 2012.
    • (2012) Draft Guidelines on Validation of Bioanalytical Methods


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.